These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38654139)
1. Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE-HF2 trial design. Anker SD; Friede T; von Bardeleben RS; Butler J; Fatima K; Diek M; Heinrich J; Hasenfuß G; Schillinger W; Ponikowski P Eur J Heart Fail; 2024 Apr; 26(4):984-993. PubMed ID: 38654139 [TBL] [Abstract][Full Text] [Related]
2. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials. Anker SD; Friede T; von Bardeleben RS; Butler J; Khan MS; Diek M; Heinrich J; Geyer M; Placzek M; Ferrari R; Abraham WT; Alfieri O; Auricchio A; Bayes-Genis A; Cleland JGF; Filippatos G; Gustafsson F; Haverkamp W; Kelm M; Kuck KH; Landmesser U; Maggioni AP; Metra M; Ninios V; Petrie MC; Rassaf T; Ruschitzka F; Schäfer U; Schulze PC; Spargias K; Vahanian A; Zamorano JL; Zeiher A; Karakas M; Koehler F; Lainscak M; Öner A; Mezilis N; Theofilogiannakos EK; Ninios I; Chrissoheris M; Kourkoveli P; Papadopoulos K; Smolka G; Wojakowski W; Reczuch K; Pinto FJ; Zmudka K; Kalarus Z; Adamo M; Santiago-Vacas E; Ruf TF; Gross M; Tongers J; Hasenfuß G; Schillinger W; Ponikowski P Eur J Heart Fail; 2024 Jul; 26(7):1608-1615. PubMed ID: 38847420 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. Mack MJ; Abraham WT; Lindenfeld J; Bolling SF; Feldman TE; Grayburn PA; Kapadia SR; McCarthy PM; Lim DS; Udelson JE; Zile MR; Gammie JS; Gillinov AM; Glower DD; Heimansohn DA; Suri RM; Ellis JT; Shu Y; Kar S; Weissman NJ; Stone GW Am Heart J; 2018 Nov; 205():1-11. PubMed ID: 30134187 [TBL] [Abstract][Full Text] [Related]
4. Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? Senni M; Adamo M; Metra M; Alfieri O; Vahanian A Eur J Heart Fail; 2019 Jul; 21(7):852-861. PubMed ID: 31116485 [TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). Naser N Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569 [TBL] [Abstract][Full Text] [Related]
6. Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization. Giaimo VL; Zappulla P; Cirasa A; Tempio D; Sanfilippo M; Rapisarda G; Trovato D; Grazia AD; Liotta C; Grasso C; Capodanno D; Tamburino C; Calvi V Pacing Clin Electrophysiol; 2018 Jan; 41(1):65-72. PubMed ID: 29139550 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial. McCarthy PM; Whisenant B; Asgar AW; Ailawadi G; Hermiller J; Williams M; Morse A; Rinaldi M; Grayburn P; Thomas JD; Martin R; Asch FM; Shu Y; Sundareswaran K; Moat N; Kar S J Am Heart Assoc; 2023 Feb; 12(4):e027504. PubMed ID: 36752231 [TBL] [Abstract][Full Text] [Related]
8. Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial. Halaby R; Herrmann HC; Gertz ZM; Lim S; Kar S; Lindenfeld J; Abraham WT; Grayburn PA; Naidu S; Asch FM; Weissman NJ; Zhang Y; Mack MJ; Stone GW JACC Cardiovasc Interv; 2021 Apr; 14(8):879-889. PubMed ID: 33888233 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. Maisano F; Franzen O; Baldus S; Schäfer U; Hausleiter J; Butter C; Ussia GP; Sievert H; Richardt G; Widder JD; Moccetti T; Schillinger W J Am Coll Cardiol; 2013 Sep; 62(12):1052-1061. PubMed ID: 23747789 [TBL] [Abstract][Full Text] [Related]
10. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial. Kosmidou I; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Kipperman RM; Boudoulas KD; Redfors B; Shahim B; Zhang Z; Mack MJ; Stone GW Circ Heart Fail; 2020 Nov; 13(11):e007293. PubMed ID: 33176460 [TBL] [Abstract][Full Text] [Related]
11. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial. Giustino G; Lindenfeld J; Abraham WT; Kar S; Lim DS; Grayburn PA; Kapadia SR; Cohen DJ; Kotinkaduwa LN; Weissman NJ; Mack MJ; Stone GW JACC Cardiovasc Interv; 2020 Oct; 13(20):2317-2328. PubMed ID: 33092705 [TBL] [Abstract][Full Text] [Related]
12. Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk Score. Shah N; Madhavan MV; Gray WA; Brener SJ; Ahmad Y; Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Lim DS; Mishell JM; Whisenant BK; Zhang Z; Redfors B; Mack MJ; Stone GW JACC Cardiovasc Interv; 2022 Oct; 15(19):1893-1905. PubMed ID: 36202557 [TBL] [Abstract][Full Text] [Related]
13. Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial. Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Asch FM; Lim DS; Nie H; Singhal P; Sundareswaran KS; Weissman NJ; Mack MJ; Stone GW; JAMA Cardiol; 2021 Apr; 6(4):427-436. PubMed ID: 33533873 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous Mitral Valve Repair Vs. Stand-Alone Medical Therapy in Patients with Functional Mitral Regurgitation and Heart Failure. Benito-González T; Estévez-Loureiro R; Villablanca PA; Armeni P; Iglesias-Gárriz I; Minguito C; Garrote C; de Prado AP; Tundidor-Sanz E; Gualis J; Fernández-Vázquez F Cardiovasc Revasc Med; 2020 Jan; 21(1):52-60. PubMed ID: 31326258 [TBL] [Abstract][Full Text] [Related]
15. Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial. Hahn RT; Asch F; Weissman NJ; Grayburn P; Kar S; Lim S; Ben-Yehuda O; Shahim B; Chen S; Liu M; Redfors B; Medvedofsky D; Puri R; Kapadia S; Sannino A; Lindenfeld J; Abraham WT; Mack MJ; Stone GW J Am Coll Cardiol; 2020 Sep; 76(11):1305-1314. PubMed ID: 32912445 [TBL] [Abstract][Full Text] [Related]
16. Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy. Godino C; Scotti A; Taramasso M; Adamo M; Russo M; Chiarito M; Melillo F; Beneduce A; Pivato CA; Arrigoni L; Toscano E; Salerno A; Cappelletti A; Magni V; Stella S; Fragasso G; Montorfano M; Agricola E; Ettori F; Margonato A; Maisano F; Colombo A Int J Cardiol; 2018 Oct; 269():33-39. PubMed ID: 29929931 [TBL] [Abstract][Full Text] [Related]
17. Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation: COAPT Trial. Arnold SV; Stone GW; Mack MJ; Chhatriwalla AK; Austin BA; Zhang Z; Ben-Yehuda O; Kar S; Lim DS; Lindenfeld J; Abraham WT; Cohen DJ; J Am Coll Cardiol; 2020 May; 75(17):2099-2106. PubMed ID: 32194195 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial. Reichenspurner H; Schillinger W; Baldus S; Hausleiter J; Butter C; Schäefer U; Pedrazzini G; Maisano F; Eur J Cardiothorac Surg; 2013 Oct; 44(4):e280-8. PubMed ID: 23864216 [TBL] [Abstract][Full Text] [Related]
19. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464 [TBL] [Abstract][Full Text] [Related]
20. Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation. Malik UI; Ambrosy AP; Ku IA; Mishell JM; Kar S; Lim DS; Whisenant BK; Cohen DJ; Arnold SV; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW JACC Cardiovasc Interv; 2020 Oct; 13(20):2331-2341. PubMed ID: 33092707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]